U.S. Markets open in 2 hrs 27 mins


. Currency in USD
Add to watchlist
Full screen
Previous CloseN/A
BidN/A x N/A
AskN/A x N/A
Day's RangeN/A - N/A
52 Week Rangeundefined - undefined
Avg. VolumeN/A
Market CapN/A
PE Ratio (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Associated Press8 hours ago

    Keryx Biopharma reports 2Q loss

    On a per-share basis, the Boston-based company said it had a loss of 77 cents. Losses, adjusted for non-recurring costs, came to 21 cents per share. The results did not meet Wall Street expectations. The ...

  • Capital Cube17 hours ago

    ETFs with exposure to Keryx Biopharmaceuticals, Inc. : July 27, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Keryx Biopharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to KERX-US. Comparing the performance and risk of Keryx Biopharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Thomson Reuters StreetEvents18 hours ago

    Edited Transcript of KERX earnings conference call or presentation 27-Jul-17 12:00pm GMT

    Q2 2017 Keryx Biopharmaceuticals Inc Earnings Call